Seinäjoki, Finland, May 18th, 2021 – Eevia releases an adjusted Interim Report for Q1-21 and makes plans to list its shares in Sweden. After a shareholders’ decision on April 21st, Eevia Health Oy has changed its legal form from a private limited company to a public limited company and became Eevia Health Oyj. In the same decision the share capital was increased to EUR 80.000, which followed a pre-IPO equity issue of EUR 1,2 million completed in January 2021.

Eevia Health Oyj is a Finnish producer of organic-certified plant extracts. The company is experiencing rapid growth and to finance needed capacity expansion, the company is preparing an Initial Public Offering (IPO). The IPO will be followed by listing for public trading of its shares at an MTF-exchange in Stockholm.

“For Eevia Health Oyj to be able to compete properly in a EUR 500 billion international nutraceuticals market, we need access to capital to meet the strong demand with more capacity” states CEO, Stein Ulve from Eevia Health Oyj.

Click here to download the report. 

For additional information, please contact:

Kim Nurmi-Aro, CFO                                                

Eevia Health Oyj                                                        

Mobile: +358 50 444 0717                                       

Email: kim@eeviahealth.com